We are live on ! Find out more
PBM icon

Psyence Biomedical
PBM

11 hedge funds and large institutions have $201K invested in Psyence Biomedical in 2024 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

150% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 2

38% more funds holding

Funds holding: 8 → 11 (+3)

12.6% more ownership

Funds ownership: 10.31% → 22.91% (+13%)

28% less capital invested

Capital invested by funds: $280K → $201K (-$79K)

Holders
11
Holders Change
+3
Holders Change %
+37.5%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
3
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AI
AdvisorShares Investments
Maryland
+$279K
2
Citadel Advisors
Citadel Advisors
Florida
+$60.9K
3
SFFS
Stonehage Fleming Financial Services
Jersey
+$29.8K
4
Jane Street
Jane Street
New York
+$16.2K
5
TRCT
Tower Research Capital (TRC)
New York
+$12.2K

Top Sellers

Rank Fund Capital Flow
1
CS
Clear Street
New York
-$6K
2
VF
Virtu Financial
New York
-$4K
3
UBS Group
UBS Group
Switzerland
-$2.71K
4
HT
Headlands Technologies
Illinois
-$8

PBM Hedge Fund Activity: Q3 2024 in Review

11 of the 6,981 institutional investors tracked by Wall St. Rank reported a position in Psyence Biomedical (PBM) for Q3 2024, worth a combined $201K — down 28% from $280K a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new PBM positions and 2 closed out — a net gain of 3 holders — while 3 added to existing stakes and 1 trimmed.

The largest buyer was AdvisorShares Investments, adding an estimated $279K. The largest seller was Clear Street, exiting entirely with an estimated $6K sold.

  • 11 institutional investors held Psyence Biomedical (PBM) as of Q3 2024, up from 8 in Q2 2024.
  • Funds reported $201K of Psyence Biomedical stock for Q3 2024, down 28% quarter-over-quarter.
  • 5 funds opened new Psyence Biomedical positions in Q3 2024 and 2 closed out, a net change of +3 holders.
  • The largest Psyence Biomedical buyer in Q3 2024 was AdvisorShares Investments, an estimated $279K added.
  • The largest Psyence Biomedical seller in Q3 2024 was Clear Street, an estimated $6K sold.

Based on aggregated 13F filings for Q3 2024.